Suppr超能文献

血管内动脉瘤修复术中输血的多因素风险指数预测。

Multifactorial risk index for prediction of intraoperative blood transfusion in endovascular aneurysm repair.

机构信息

Feinberg School of Medicine, Northwestern University, Chicago, Ill; Department of Anesthesia, Critical Care, and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.

Department of Anesthesia, Critical Care, and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass.

出版信息

J Vasc Surg. 2018 Mar;67(3):778-784. doi: 10.1016/j.jvs.2017.06.106. Epub 2017 Sep 29.

Abstract

BACKGROUND

In some institutions, the current blood ordering practice does not discriminate minimally invasive endovascular aneurysm repair (EVAR) from open procedures, with consequent increasing costs and likelihood of blood product wastage for EVARs. This limitation in practice can possibly be addressed with the development of a reliable prediction model for transfusion risk in EVAR patients. We used the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) database to create a model for prediction of intraoperative blood transfusion occurrence in patients undergoing EVAR. Afterward, we tested our predictive model on the Vascular Study Group of New England (VSGNE) database.

METHODS

We used the ACS NSQIP database for patients who underwent EVAR from 2011 to 2013 (N = 4709) as our derivation set for identifying a risk index for predicting intraoperative blood transfusion. We then developed a clinical risk score and validated this model using patients who underwent EVAR from 2003 to 2014 in the VSGNE database (N = 4478).

RESULTS

The transfusion rates were 8.4% and 6.1% for the ACS NSQIP (derivation set) and VSGNE (validation) databases, respectively. Hemoglobin concentration, American Society of Anesthesiologists class, age, and aneurysm diameter predicted blood transfusion in the derivation set. When it was applied on the validation set, our risk index demonstrated good discrimination in both the derivation and validation set (C statistic = 0.73 and 0.70, respectively) and calibration using the Hosmer-Lemeshow test (P = .27 and 0.31) for both data sets.

CONCLUSIONS

We developed and validated a risk index for predicting the likelihood of intraoperative blood transfusion in EVAR patients. Implementation of this index may facilitate the blood management strategies specific for EVAR.

摘要

背景

在一些机构中,目前的血液订购实践并没有将微创血管内动脉瘤修复(EVAR)与开放手术区分开来,因此 EVAR 的成本增加,并且有可能浪费血液制品。这种实践中的局限性可以通过开发用于 EVAR 患者输血风险的可靠预测模型来解决。我们使用美国外科医师学会国家手术质量改进计划(ACS NSQIP)数据库为接受 EVAR 的患者创建了一个用于预测术中输血发生的模型。之后,我们在新英格兰血管研究组(VSGNE)数据库上测试了我们的预测模型。

方法

我们使用 ACS NSQIP 数据库中的 2011 年至 2013 年接受 EVAR 的患者(N=4709)作为我们的推导集,以确定预测术中输血的风险指数。然后,我们开发了一个临床风险评分,并使用 VSGNE 数据库中 2003 年至 2014 年接受 EVAR 的患者(N=4478)验证了该模型。

结果

ACS NSQIP(推导集)和 VSGNE(验证集)数据库的输血率分别为 8.4%和 6.1%。血红蛋白浓度、美国麻醉医师协会分类、年龄和动脉瘤直径在推导集中预测了输血。当应用于验证集时,我们的风险指数在推导集和验证集均表现出良好的区分度(C 统计量分别为 0.73 和 0.70),Hosmer-Lemeshow 检验(P 分别为 0.27 和 0.31)表明校准良好。

结论

我们开发并验证了一个预测 EVAR 患者术中输血可能性的风险指数。实施该指数可以促进针对 EVAR 的血液管理策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验